Member Info for Jimzi

PDS Biotechnology
Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing
novel cancer therapies based on the Company’s proprietary Versamune® T-cell
activating technology, was added to the Russell Microcap® Index at the
conclusion of the 2021 Russell indexes annual reconstitution, effective on
June 28,

Don't be silly.

A DIM float announcement will send this flying - fund raise needed miniscule .
And you have to be in before its announced - the sp now matters not to me.

I don't get why there are so many nervous peeps around atm.

There's over 3000 aim cos that I would be nervous about!

They bought the placing. There are no large trades relating to them .

So you believe one director and abuse another from the same group? It’s one company!
Armchair dickie with zero analytical ability. Or credibility.

Smell trading his own book methinks

Gl anyway

Yep, totally out of sync with RSP
250k was 9.4 / 7.65 quite all day.
So yes, it’s kind of funny. Wink

Draw- how do you figure that out. ?

Oh go on - hold your breath!!
See, language can be both figurative and specific

Off out for lobster and steak

The whole bb is becoming pointless as all it focuses on is what days and weeks mean in an absolute determinable timeframe- which there isn’t one - ergo pointless

I’ll be round in a minute and I arrive in 61 seconds- angry?

Some just show their insecurity.

Yep, up 47% over placing price.
And with Cantor forecast at 24 - its being taken very seriously in the US

Ah, so many disciples who vowed allegiance to end - and there out in 2 weeks

Welcome to “investing”

Trade away kids

Clearly people who can spot the deal of the decade aka reconciliation!

True - but who controls the news flow?

V easy to delay / obfuscate if your in control.

I am a firm conspiracy believer when it comes to loads of cash - been happening since the dawn of man.

You may have a point.
Converting in Dec spooks many PI.
Last rise and he converted nothing [and vol was there to take em out]
15m fleeced from PIs !!! or 7% of the free float.

We all know he's a canny one - and holds 29.5%!!

I wouldn't call it fair value but the 38% excess over mcap at the RNS date is:

PDS 14m
Glyco - 10m

24m versus 17m [macp at that point pre-cash] = 40%

The clues are in the 5/8 RNS placing doc.

I think we have 2 very bored traders !!

selling thinking BOD sold!!

Its just the % dilution from the placing LMAO

Fair value has further increased and is up c. 40% on the year end now representing a premium to our market value of 38%

· Capital Under Advisory enhanced growth, up c.20% on the year end through several transactions, and demonstrating the capital light model in action

* Brokerage Cantor Fitzgerald starts coverage on drug developer with "overweight" rating; believes co has promising pipeline of cancer and infectious diseases therapies and that peak sales potential for co's lead immunotherapy candidate, PDS0101, remains underappreciated
* Sets PT at $25, a premium of 127.3% to PDSB's last close
* Brokerage sees many upcoming potential stock-moving catalysts including data from trials testing PDS0101 in advanced human papillomavirus (HPV)- associated cancers and in advanced cervical cancer
* Adds that two other potential cancer therapies - PDS0102 and PDS0103 - are also entering clinical testing in H1 of 2022
* Upwards earnings revision, driven by pipeline advancements, should move the stock higher - Cantor
* Stock up 1.3% at $11.15 premarket

Why not wait until the presentation on Wed?

Need a lot more vol to prove but praise be a floor seems to have reached

Man pursues advances for profit and human well being - the two can be co-joined to show there is more than one avenue to mutual societal benefit or do your own fooking research.